Sponsored Content
Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes
The drug could also reduce chronic kidney disease when combined with insulin therapy.
Wicked Good Cardiometabolic Chat: Compounded Weight Loss Medications
In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.
Sleep Habits Could Influence Risk of Type 2 Diabetes
Investigators also found that a change in brain functional network connectivity could also be associated with type 2 diabetes risk.
The Pharmacist’s Role in Counseling Patients on GLP-1 Medications
With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.
Diabetes Risk Reduction Practices Low for Women With Gestational Diabetes
For women in rural populations, access to education and care is limited, causing disparities in diabetes care.
Steatosis Liver Disease Shows Increased Risk of Diabetes for Patients With Atrial Fibrillation
Investigators find that the risk for new-onset diabetes is especially prominent for patients aged 20 to 29 years.
